Results 261 to 270 of about 787,562 (301)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 2017
Key Clinical PointsSocial Anxiety Disorder Social anxiety disorder affects up to 13% of the U.S. population and is characterized by an intense fear of social situations in which the person anticipates being evaluated negatively. Social anxiety is associated with an increased risk of other mental disorders, such as depression and substance-use disorder.
Falk, Leichsenring, Frank, Leweke
openaire +2 more sources
Key Clinical PointsSocial Anxiety Disorder Social anxiety disorder affects up to 13% of the U.S. population and is characterized by an intense fear of social situations in which the person anticipates being evaluated negatively. Social anxiety is associated with an increased risk of other mental disorders, such as depression and substance-use disorder.
Falk, Leichsenring, Frank, Leweke
openaire +2 more sources
Medical Clinics of North America, 2001
In 1990s, it was found that GSAD is more common, more disabling, and more chronic than previously realized. For the first time, there are good data about a range of effective treatment options that can offer these patients substantial relief and protection from their disability.
B A, Raj, D V, Sheehan
openaire +2 more sources
In 1990s, it was found that GSAD is more common, more disabling, and more chronic than previously realized. For the first time, there are good data about a range of effective treatment options that can offer these patients substantial relief and protection from their disability.
B A, Raj, D V, Sheehan
openaire +2 more sources
Pride in social anxiety disorder
Journal of Anxiety Disorders, 2023The present study examined differences in the experience of pride between individuals with and without social anxiety disorder (SAD), and is the first to examine both the effects of context on pride and the temporal relationship between pride and anxiety in participants' daily lives.
Roni, Oren-Yagoda +2 more
openaire +2 more sources
Sertraline for social anxiety disorder
Expert Review of Neurotherapeutics, 2003Social anxiety disorder is a common, chronic and often debilitating condition. Selective serotonin reuptake inhibitors have been widely used for the treatment of anxiety disorders, with more data currently available for paroxetine. With its beneficial side-effect profile and proven efficacy in social anxiety disorder, sertraline can be considered a ...
Marina, Sokolenko, Stan, Kutcher
openaire +2 more sources
Tiagabine for social anxiety disorder
Human Psychopharmacology: Clinical and Experimental, 2007AbstractTiagabine, a selective gamma‐aminobutyric acid (GABA) reuptake inhibitor was evaluated for the treatment of patients with social anxiety disorder (SAD). Adults with SAD received open‐label tiagabine 4–16 mg per day for 12 weeks. Intent‐to‐treat data are available for 54 patients with improvement demonstrated in Liebowitz Social Anxiety Scale ...
Boadie W, Dunlop +5 more
openaire +2 more sources
Hyperhidrosis in social anxiety disorder
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2002Excessive sweating (hyperhidrosis) is an overlooked and potentially disabling symptom, which is often seen in social anxiety disorder (SAD). We conducted a retrospective review of data acquired in patients with SAD who had participated in placebo-controlled clinical trials of fluoxetine, cognitive behavior therapy, clonazepam and gabapentin.
Jonathan R T, Davidson +3 more
openaire +2 more sources
Anger in social anxiety disorder
Cognitive Behaviour TherapyThe present study focused on the emotional experience of anger among individuals with and without social anxiety disorder (SAD). Eighty-eight participants took part in the study, half (n = 44) met diagnostic criteria for SAD and half (n = 44) did not meet criteria for SAD.
Roni Oren-Yagoda +2 more
openaire +2 more sources
Social anxiety disorder in callers to the Anxiety Disorders Association of America
Depression and Anxiety, 2004Social anxiety disorder (SAD) is among the most common anxiety disorders with a lifetime prevalence of up to 16%. Among callers to the Anxiety Disorders Association of America (ADAA), we surveyed 1,000 participants using a 97-item questionnaire to understand the characteristics of participants with SAD and subthreshold SAD (SSAD).
Wei, Zhang +2 more
openaire +2 more sources
Pharmacotherapy of Social Anxiety Disorder
2009A range of medications have been shown effective for the treatment of social anxiety disorder. The largest trials to date have been with various selective serotonin reuptake inhibitors (SSRIs). Several of these agents have been registered for the treatment of social anxiety disorder with agencies such as the FDA or EMEA, meta-analyses confirm their ...
Keith A, Ganasen, Dan J, Stein
openaire +2 more sources
Pharmacotherapy for Social Anxiety Disorder
Issues in Mental Health Nursing, 2018Social anxiety disorder (SAnD or SAD) is characterised by excessive fear and distress in social or performance situations, and associated with numerous functional impairments such as academic and o...
openaire +3 more sources